Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bone Mineral Density in Hemophilia and VWD.

Blood advances·2026
Same author

Inhibition of endolysosomal two-pore channel 2 (TPC2) induces osteoblast differentiation and matrix mineralization while targeting autophagy.

Journal of endocrinological investigation·2026
Same author

ADAR2 induces the differentiation of osteosarcoma cells by editing activity on IGFBP7: new implications for therapy.

Bone research·2026
Same author

Reply: Lung organoids: a new frontier in neonatology and paediatric respiratory medicine.

European respiratory review : an official journal of the European Respiratory Society·2026
Same author

Extracellular Vesicles From Mesenchymal Stromal Cells Drive Muscle and Neuronal Regeneration Through TNFα Modulation.

Journal of extracellular vesicles·2026
Same author

Key Principles and Disease-Specific Considerations to Guide Management of Bone Health and Osteoporosis Among Individuals With Neuromuscular Disorders: The Path Forward.

Muscle & nerve·2026

Related Experiment Video

Updated: Apr 14, 2026

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases
09:48

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Published on: August 23, 2024

858

Nanoparticles-Based Treatment for Bone Metastasis.

Rossana Saracino, Rosa Luciano, Giulia Battafarano

  • 1Regenerative Medicine Unit, Bambino Gesù Children's Hospital, IRCCS Viale di San Paolo 15 00146, Rome, Italy. andrea.delfattore@opbg.net.

Current Drug Targets
|April 28, 2015
PubMed
Summary

Bone metastasis, common in prostate cancer, significantly reduces survival and increases skeletal events. Nanomedicine offers a promising avenue for developing safer and more targeted treatments for bone metastases.

More Related Videos

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells
10:01

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

8.6K
Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
09:02

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

3.2K

Related Experiment Videos

Last Updated: Apr 14, 2026

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases
09:48

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Published on: August 23, 2024

858
Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells
10:01

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

8.6K
Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
09:02

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

3.2K

Area of Science:

  • Oncology
  • Nanomedicine
  • Skeletal Biology

Background:

  • Bone is a primary site for metastasis in carcinomas like prostate cancer.
  • Bone metastases lead to decreased survival and increased skeletal-related events (fractures, pain, hypercalcemia).
  • The development of bone metastases involves a complex interplay between tumor cells and the bone microenvironment, known as the 'vicious cycle'.

Purpose of the Study:

  • To review emerging nanomedicine approaches for treating bone metastasis.
  • To highlight the potential of nanomedicine in overcoming limitations of current therapies.
  • To discuss the development of more specific and safer treatments for bone metastases.

Main Methods:

  • Literature review of current research on bone metastasis.
  • Analysis of existing therapeutic strategies targeting the bone metastasis vicious cycle.
  • Exploration of nanomedicine applications in preclinical and clinical studies.

Main Results:

  • Current therapies for bone metastasis have significant adverse effects.
  • Nanomedicine offers novel strategies to target tumor cells and the bone microenvironment.
  • Emerging nanomedicine approaches show potential for improved specificity and safety.

Conclusions:

  • Nanomedicine represents a promising frontier for innovative bone metastasis treatments.
  • Targeting the vicious cycle with nanomedicine could improve patient outcomes.
  • Further research in nanomedicine is crucial for developing next-generation therapies for bone metastases.